𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Early phase II study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancer

✍ Scribed by K. Furuse; M. Kawahara; K. Hasegawa; S. Kudoh; M. Takada; T. Sugiura; Y. Ichinose; M. Fukuoka; Y. Ohashi; H. Niitani; for the S-1 Cooperative Study Group (Lung Cancer Working Group)

Publisher
Springer
Year
2001
Tongue
English
Weight
96 KB
Volume
6
Category
Article
ISSN
1341-9625

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II clinical and pharmacological st
Phase II clinical and pharmacological study of oral 4-demethoxydaunorubicin in advanced non-pretreated small cell lung cancer
✍ Robert Milroy; Jeffrey Cummings; Stanley B. Kaye; Stephen W. Banham πŸ“‚ Article πŸ“… 1987 πŸ› Springer 🌐 English βš– 298 KB

4-Demethoxydaunorubicin (4-DMDNR) is an oral anthracycline with antitumour activity demonstrated in a number of clinical studies. We have assessed the usefulness of 4-DMDNR in 16 patients with advanced small cell lung cancer, none of whom had received previous chemotherapy. There were no complete or